Mucosal nirsevimab levels in respiratory syncytial virus breakthrough bronchiolitis

Sylvie Pillet1, Aymeric Cantais2, Blandine Noailly3

  • 1CIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, CIC 1408 Vaccinology, F42023 Saint-Etienne, France; Department of Infectious Agents and Hygiene, University-Hospital of Saint-Etienne, Saint-Etienne, France.

Summary

No abstract available in PubMed .

Related Concept Videos